Physician profile
Robert Phillips
NPI 1033182290
$1,176.17
in general payments reported to CMS, 2019-2025
12 companies · $73.35 in 2025
The $73.35 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.36 · 2020: $54.80 · 2021: $700 · 2022: $196 · 2023: $19.93 · 2024: $120 · 2025: $73.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $723.36 | 2021-2025 | Konect Resilia |
| Abbott Laboratories | $119.70 | 2024 | Esprit |
| Abiomed | $101.40 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.96 | 2019-2021 | |
| Medtronic, INC. | $46.74 | 2021 | |
| Janssen Pharmaceuticals, INC | $39.25 | 2021 | |
| Endologix LLC | $22.80 | 2022 | |
| Lantheus Medical Imaging, INC. | $19.93 | 2023 | Definity |
| Astrazeneca Pharmaceuticals Lp | $16.78 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.34 | 2022 | |
| Amgen INC. | $11.35 | 2021 | |
| Veran Medical Technologies, INC. | $8.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.